How To Invest In Phathom Pharmaceuticals, Inc. Stock - PHAT Share Price Today & News | Stash

Invest in Phathom Pharmaceuticals, Inc. on Stash

Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company.

To buy fractional shares of Phathom Pharmaceuticals, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.

Ticker: PHAT

Phathom Pharmaceuticals, Inc.

$10.94

-10.03%
(1W)
Jul ’26Jul ’26$11$12$13

$

1W1M1Y5Y

PHAT Performance Breakdown

Share Price
The last publicly stated price for one share of an investment, updated every approximately 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).

$10.94

Today's change
This is how much an investment's price has changed over the last day of active trading. For example, if an investment's price was $10 yesterday, and today it rose to $11, you'd see a 1 day change of 10%.

-0.27%

Year to date change (YTD)
This is the performance of the investments since the start of the year, updated approximately every 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).

-30.36%

Dividend yield
Some investments pay you profits or interest as you hold them. These payments are called dividends, and this value represents the dollar value as a percentage of the investment's share price.

0.0

Last dividend paid
The dollar value per share that was paid out to shareholders.

N/A

Last dividend pay date
The date shareholders were paid out for the last dividend issued.

N/A

About PHAT

Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule potassium competitive acid blocker (P-CAB). It is developing vonoprazan as an agent in the treatment of gastroesophageal reflux disease (GERD) and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. Vonoprazan accumulates in the secretory canaliculus where the proton pumps are present in their active state. Vonoprazan binds to proton pumps in both their inactive and active states and remains in the secretory canaliculus where it continues to inhibit acid secretion over an extended period.